Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara McGovern

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|December 20, 2007
Antiretroviral drugs and liver injuryVincent Soriano, Massimo Puoti, Pilar Garcia-Gascó, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Antiretroviral drug resistance mutations in antiretroviral-naive prisonersDavid R Stone, Colleen Corcoran, Alysse Wurcel, et al.
The Journal of Infectious Diseases|April 6, 2005
Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategiesRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Journal of Virology|November 20, 2002
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infectionCheryl L Day, Georg M Lauer, Gregory K Robbins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2003
Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigenRajesh T Gandhi, Alysse Wurcel, Barbara McGovern, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individualsRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Journal of Hepatology|April 4, 2015
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphineJacob Lalezari, J Greg Sullivan, Peter Varunok, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2005
Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patientsBarbara McGovern, Joseph Fiore, Alysse Wurcel, et al.
The Journal of Experimental Medicine|January 4, 2012
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistenceJulian Schulze Zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, et al.
JAMA Network Open|January 30, 2023
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical TrialKevin W Garey, Jinhee Jo, Anne J Gonzales-Luna, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|December 20, 2007
Antiretroviral drugs and liver injuryVincent Soriano, Massimo Puoti, Pilar Garcia-Gascó, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Antiretroviral drug resistance mutations in antiretroviral-naive prisonersDavid R Stone, Colleen Corcoran, Alysse Wurcel, et al.
The Journal of Infectious Diseases|April 6, 2005
Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategiesRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Journal of Virology|November 20, 2002
Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infectionCheryl L Day, Georg M Lauer, Gregory K Robbins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2003
Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigenRajesh T Gandhi, Alysse Wurcel, Barbara McGovern, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individualsRajesh T Gandhi, Alysse Wurcel, Hang Lee, et al.
Journal of Hepatology|April 4, 2015
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphineJacob Lalezari, J Greg Sullivan, Peter Varunok, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2005
Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patientsBarbara McGovern, Joseph Fiore, Alysse Wurcel, et al.
The Journal of Experimental Medicine|January 4, 2012
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistenceJulian Schulze Zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, et al.
JAMA Network Open|January 30, 2023
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical TrialKevin W Garey, Jinhee Jo, Anne J Gonzales-Luna, et al.
Pageof 3